A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis

NCT01604265 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis
Neuropathic Pain

Interventions

DRUG: Placebo
DRUG: Sativex

Sponsor

Jazz Pharmaceuticals